Agent for the regulation of the appetite or a sleeping agent
AssigneeCharlotte Erlanson-Albertsson
InventorCharlotte Erlanson-Albertsson
Life of this patent
Estimating the term…
Abstract
An agent for the regulation of the appetite or a sleeping agent, which consists of the activation peptide in procolipase, consisting of the peptide sequence X-Pro-Y-Pro-Arg wherein a) X is Ala and Y is Gly, or b) X is Val and Y is Asp, or a derivative thereof.
Claims4
A method of decreasing appetite in mammals comprising administering to a mammal in need of such treatment a pharmaceutical composition comprising as active ingredient an amount of a peptide selected from the group consisting of Ala-Pro-Gly-Pro-Arg, Val-Pro-Asp-Pro-Arg, Ala-Pro-Gly-Pro-Arg having a C-terminal amide and Val-Pro-Asp-Pro-Arg having a C-terminal amide, effective to decrease the mammal's appetite.
A method of decreasing appetite in mammals comprising administering to a mammal in need of such treatment a pharmaceutical composition comprising as active ingredient an amount of a peptide selected from the group consisting of Ala-Pro-Gly-Pro-Arg bound to a synthetic polymer and Val-Pro-Asp-Pro-Arg bound to a synthetic polymer, effective to decrease the mammal's appetite.
A method of decreasing appetite in mammals comprising administering to a mammal in need of such treatment a pharmaceutical composition comprising as active ingredient an amount of human procolipase which includes at its N-terminal end the sequence Ala-Pro-Gly-Pro-Arg effective to decrease the mammal's appetite.
A method of decreasing appetite in mammals comprising administering to a mammal in need of such treatment a pharmaceutical composition comprising as active ingredient an amount of nonhuman procolipase which includes at its N-terminal end Val-Pro-Asp-Pro-Arg effective to decrease the mammal's appetite.
Dependencies are inferred from the claim text.